Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFDA Announces Quality Standards For In Vitro Diagnostic Reagents

This article was originally published in PharmAsia News

Executive Summary

China FDA released quality standards for vitro diagnostic reagents, covering staffing, quality management, and facility requirements.

China FDA released quality standards for vitro diagnostic reagents, covering staffing, quality management, and facility requirements. Employees responsible for managing should be college-educated and possess relevant product and legal knowledge, and the chief QA officer should have relevant college education and three years of experience. The standards also span production, storage, low-temperature storage environments, logistics, information systems and facility maintenance. (Click Here For More - Chinese Language)

"CFDA: In Vitro Reagent (Med Device) Quality Standards For Product Acceptance" - news.pharmnet.com.cn (5/23/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC084434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel